AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021
May 13, 2021
30583_dirs_2021-05-12_1a6a2b17-9f92-4cfd-b299-23d7e20b380b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-05-10
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-10 | Common Stock | M | 8513 | $26.49 | Acquired | 312352 | Direct |
| 2021-05-10 | Common Stock | S | 8513 | $77.29 | Disposed | 303839 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-10 | Stock Option (Right to buy Common Stock) | $26.49 | M | 8513 | Disposed | 2021-05-11 | Common Stock (8513) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 247533 | Indirect |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.
F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19